Authors: Mohty, M Fegueux, N Exbrayat, C Lu, ZY Legouffe, E Quittet, P Lopez-Martinez, E Latry, P Avinens, O Hertog, C Klein, B Eliaou, JF Rossi, JF

Citation: M. Mohty et al., Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy, BONE MAR TR, 28(4), 2001, pp. 335-339

Authors: Dereure, O Bessis, D Lavabre-Bertrand, T Exbrayat, C Fegueux, N Biron, C Guilhou, JJ

Citation: O. Dereure et al., Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony-stimulating factor treatment, BR J DERM, 142(4), 2000, pp. 834-836

Authors: Exbrayat, C Garnier, A Colonna, M Assouline, D Salicru, B Winckel, P Menegoz, F Bolla, M

Citation: C. Exbrayat et al., Analysis and classification of interval cancers in a French breast cancer screening programme (departement of Isere), EUR J CAN P, 8(3), 1999, pp. 255-260

Authors: Menegoz, F Exbrayat, C Sousbie, M Laforet, C Colonna, M Veran-Peyret, MF Schaerer, R

Citation: F. Menegoz et al., Patterns in health care delivery systems for breast cancers in Isere (France-1995), REV EPIDEM, 47(5), 1999, pp. 443-453

Authors: Faure, H Exbrayat, C Garnier, A Dumas, P Winckel, P Bolla, M

Citation: H. Faure et al., Influence of the 'Directions for use' on positivity rates of the HemoccultII (R) test, EUR J GASTR, 10(12), 1998, pp. 1021-1024